Patents

Skin Treatments Patented by Topix Pharmaceuticals

US Patent 12,016,939 B2 contains retinol and an activation solvent.

US Patent No. 12,016,939 B2 (Steven M. Hernandez), Topix Pharamceuticals, North Amityville, NY, patented a method for therapeutic treatment of a dermatological condition. It entails topically applying to skin a formulation comprised of a skin treatment active agent comprising retinol and an activation solvent system comprising isopentyldiol, ethoxydiglycol, dimethyl isosorbide, and a non-ionic surfactant. The topical formulation further comprises retinol, ethoxydiglycol, isopentyldiol, dimethylisorbide, and of a non-ionic surfactant selected from polysorbate 80, polysorbate 20, or a combination thereof.

Keep up with the story. Subscribe to the Happi free daily
newsletter

Related Breaking News